BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28270189)

  • 1. Characterization of the HLA-DRβ1 third hypervariable region amino acid sequence according to charge and parental inheritance in systemic sclerosis.
    Gentil CA; Gammill HS; Luu CT; Mayes MD; Furst DE; Nelson JL
    Arthritis Res Ther; 2017 Mar; 19(1):46. PubMed ID: 28270189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief Report: HLA-DRB1, DQA1, and DQB1 in Juvenile-Onset Systemic Sclerosis.
    Stevens AM; Kanaan SB; Torok KS; Medsger TA; Mayes MD; Reveille JD; Klein-Gitelman M; Reed AM; Lee T; Li SC; Henstorf G; Luu C; Aydelotte T; Nelson JL
    Arthritis Rheumatol; 2016 Nov; 68(11):2772-2777. PubMed ID: 27214100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen (HLA)-DRB1 allele polymorphisms and systemic sclerosis.
    Xu Y; Mo N; Jiang Z; Lu S; Fu S; Wei X; Zhao D; Xie Z; Jia W; Liu J; Wang X; Shi D; Jiao Y; Liu C; Yang X
    Mod Rheumatol; 2019 Nov; 29(6):984-991. PubMed ID: 30175673
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis.
    Vigone B; Santaniello A; Marchini M; Montanelli G; Caronni M; Severino A; Beretta L
    Rheumatology (Oxford); 2015 Apr; 54(4):707-11. PubMed ID: 25231181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HLA-DRB1*15:02 and DRB5*01:02 allele with the susceptibility to systemic sclerosis in Thai patients.
    Louthrenoo W; Kasitanon N; Wichainun R; Wangkaew S; Sukitawut W; Ohnogi Y; Nakaue N; Kuwata S; Takeuchi F
    Rheumatol Int; 2013 Aug; 33(8):2069-77. PubMed ID: 23404077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian women.
    Loubière LS; Lambert NC; Madeleine MM; Porter AJ; Mullarkey ME; Pang JM; Galloway DA; Furst DE; Nelson JL
    Rheumatology (Oxford); 2005 Mar; 44(3):318-22. PubMed ID: 15572392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the HLA-DRB1 with scleroderma in Chinese population.
    He D; Wang J; Yi L; Guo X; Guo S; Guo G; Tu W; Wu W; Yang L; Xiao R; Li Y; Chu H; Lai S; Jin L; Zou H; Reveille JD; Assassi S; Mayes MD; Zhou X
    PLoS One; 2014; 9(9):e106939. PubMed ID: 25184637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen association in systemic sclerosis patients: our experience at a tertiary care center in North India.
    Machhua S; Sharma SK; Kumar Y; Singh S; Aggarwal R; Anand S; Kumar M; Singh H; Minz RW
    Front Immunol; 2023; 14():1179514. PubMed ID: 37781395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases.
    Flåm ST; Gunnarsson R; Garen T; ; Lie BA; Molberg Ø
    Rheumatology (Oxford); 2015 Mar; 54(3):528-35. PubMed ID: 25187641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of X Chromosome Inactivation with Respect to HLA Genetic Susceptibility in Rheumatoid Arthritis and Systemic Sclerosis.
    Kanaan SB; Onat OE; Balandraud N; Martin GV; Nelson JL; Azzouz DF; Auger I; Arnoux F; Martin M; Roudier J; Ozcelik T; Lambert NC
    PLoS One; 2016; 11(6):e0158550. PubMed ID: 27355582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.
    Ueki A; Isozaki Y; Tomokuni A; Ueki H; Kusaka M; Tanaka S; Otsuki T; Sakaguchi H; Hyodoh F
    Immunobiology; 2001 Dec; 204(4):458-65. PubMed ID: 11776400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HLA class II genes with systemic sclerosis in Koreans.
    Kang SH; Park MH; Song EY; Kang SJ; Lee EB; Song YW; Takeuchi F
    J Rheumatol; 2001 Jul; 28(7):1577-83. PubMed ID: 11469465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes.
    Acosta-Herrera M; Kerick M; Lopéz-Isac E; Assassi S; Beretta L; Simeón-Aznar CP; Ortego-Centeno N; ; Proudman SM; ; Hunzelmann N; Moroncini G; de Vries-Bouwstra JK; Orozco G; Barton A; Herrick AL; Terao C; Allanore Y; Brown MA; Radstake TR; Fonseca C; Denton CP; Mayes MD; Martin J
    Ann Rheum Dis; 2021 Aug; 80(8):1040-1047. PubMed ID: 34096881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.
    Vlachoyiannopoulos PG; Dafni UG; Pakas I; Spyropoulou-Vlachou M; Stavropoulos-Giokas C; Moutsopoulos HM
    Ann Rheum Dis; 2000 May; 59(5):359-67. PubMed ID: 10784518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of HLA-DRB1 gene alleles in patients with multiple sclerosis in a Lithuanian population.
    Balnytė R; Rastenytė D; Mickevičienė D; Vaitkus A; Skrodenienė E; Vitkauskienė A
    Medicina (Kaunas); 2012; 48(1):9-14. PubMed ID: 22370504
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Gourh P; Safran SA; Alexander T; Boyden SE; Morgan ND; Shah AA; Mayes MD; Doumatey A; Bentley AR; Shriner D; Domsic RT; Medsger TA; Ramos PS; Silver RM; Steen VD; Varga J; Hsu V; Saketkoo LA; Schiopu E; Khanna D; Gordon JK; Kron B; Criswell LA; Gladue H; Derk CT; Bernstein EJ; Bridges SL; Shanmugam VK; Kolstad KD; Chung L; Kafaja S; Jan R; Trojanowski M; Goldberg A; Korman BD; Steinbach PJ; Chandrasekharappa SC; Mullikin JC; Adeyemo A; Rotimi C; Wigley FM; Kastner DL; Boin F; Remmers EF
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):552-562. PubMed ID: 31871193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea.
    Joung CI; Jun JB; Chung WT; Song GG; Choe JY; Chang HK; Yoo DH
    Scand J Rheumatol; 2006; 35(1):39-43. PubMed ID: 16467040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of TAP1 and TAP2 gene polymorphisms with systemic sclerosis in Korean patients.
    Song YW; Lee EB; Whang DH; Kang SJ; Takeuchi F; Park MH
    Hum Immunol; 2005 Jul; 66(7):810-7. PubMed ID: 16112028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA markers for poor prognosis in systemic sclerosis Brazilian patients.
    Del Rio AP; Sachetto Z; Sampaio-Barros PD; Marques-Neto JF; Londe AC; Bertolo MB
    Dis Markers; 2013; 35(2):73-8. PubMed ID: 24167351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.